» Articles » PMID: 36600003

Epidemiology and Modifiable Risk Factors for Atrial Fibrillation

Overview
Journal Nat Rev Cardiol
Date 2023 Jan 4
PMID 36600003
Authors
Affiliations
Soon will be listed here.
Abstract

The global prevalence of atrial fibrillation (AF) has increased substantially over the past three decades and is currently approximately 60 million cases. Incident AF and its clinical consequences are largely the result of risk factors that can be modified by lifestyle changes. In this Review, we provide evidence that the lifetime risk of AF is modified not only by sex and race but also through the clinical risk factor and comorbidity burden of individual patients. We begin by summarizing the epidemiology of AF, focusing on non-modifiable and modifiable risk factors, as well as targets and strategies for the primary prevention of AF. Furthermore, we evaluate the role of modifiable risk factors in the secondary prevention of AF as well as the potential effects of risk factor interventions on the frequency and severity of subsequent AF episodes. We end the Review by proposing strategies that require evaluation as well as global policy changes that are needed for the prevention of incident AF and the management of recurrent episodes in patients already affected by AF.

Citing Articles

Sex-specific trends in the global burden and risk factors of atrial fibrillation and flutter from 1990 to 2021.

Peng X, Wang J, Tang C, He L, Li J, Xia S Sci Rep. 2025; 15(1):8092.

PMID: 40057583 PMC: 11890608. DOI: 10.1038/s41598-025-93338-1.


Association of healthy lifestyle and the incidence of atrial fibrillation in senior adults: a prospective cohort study.

Deng H, Mei Y, Wu C, Gong C, Lai Z, Huang J BMC Geriatr. 2025; 25(1):160.

PMID: 40055644 PMC: 11889794. DOI: 10.1186/s12877-025-05825-9.


Advancing Atrial Fibrillation Research: The Role of Animal Models, Emerging Technologies and Translational Challenges.

Ferreira M, Geraldes V, Felix A, Oliveira M, Laranjo S, Rocha I Biomedicines. 2025; 13(2).

PMID: 40002720 PMC: 11853233. DOI: 10.3390/biomedicines13020307.


Global, regional, and national burden of atrial fibrillation and atrial flutter from 1990 to 2021: sex differences and global burden projections to 2046-a systematic analysis of the Global Burden of Disease Study 2021.

Tan S, Zhou J, Veang T, Lin Q, Liu Q Europace. 2025; 27(2).

PMID: 39947238 PMC: 11879048. DOI: 10.1093/europace/euaf027.


Machine Learning in the Management of Patients Undergoing Catheter Ablation for Atrial Fibrillation: Scoping Review.

Luo A, Chen W, Zhu H, Xie W, Chen X, Liu Z J Med Internet Res. 2025; 27:e60888.

PMID: 39928932 PMC: 11851043. DOI: 10.2196/60888.


References
1.
Roth G, Mensah G, Johnson C, Addolorato G, Ammirati E, Baddour L . Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020; 76(25):2982-3021. PMC: 7755038. DOI: 10.1016/j.jacc.2020.11.010. View

2.
Odutayo A, Wong C, Hsiao A, Hopewell S, Altman D, Emdin C . Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016; 354:i4482. DOI: 10.1136/bmj.i4482. View

3.
Chugh S, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin E . Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2013; 129(8):837-47. PMC: 4151302. DOI: 10.1161/CIRCULATIONAHA.113.005119. View

4.
Schnabel R, Yin X, Gona P, Larson M, Beiser A, McManus D . 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015; 386(9989):154-62. PMC: 4553037. DOI: 10.1016/S0140-6736(14)61774-8. View

5.
Lloyd-Jones D, Wang T, Leip E, Larson M, Levy D, Vasan R . Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004; 110(9):1042-6. DOI: 10.1161/01.CIR.0000140263.20897.42. View